PubRank

Jacek Hawiger

Author PubWeight™ 17.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat Med 2005 1.88
2 Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny. Immunity 2006 1.82
3 Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway. J Biol Chem 2005 1.70
4 Nuclear import of proinflammatory transcription factors is required for massive liver apoptosis induced by bacterial lipopolysaccharide. J Biol Chem 2004 1.49
5 Suppression of acute lung inflammation by intracellular peptide delivery of a nuclear import inhibitor. Mol Ther 2009 1.03
6 Receptor/transporter-independent targeting of functional peptides across the plasma membrane. J Biol Chem 2003 1.00
7 Suppression of Staphylococcal Enterotoxin B-induced Toxicity by a Nuclear Import Inhibitor. J Biol Chem 2004 0.94
8 Intracellular delivery of a cell-penetrating SOCS1 that targets IFN-gamma signaling. Sci Signal 2009 0.90
9 In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes. PLoS One 2010 0.88
10 Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxin. J Immunol 2008 0.87
11 Targeting nuclear import shuttles, importins/karyopherins alpha by a peptide mimicking the NFκB1/p50 nuclear localization sequence. J Am Heart Assoc 2013 0.85
12 Extended anti-inflammatory action of a degradation-resistant mutant of cell-penetrating suppressor of cytokine signaling 3. J Biol Chem 2010 0.83
13 Nuclear transport modulation reduces hypercholesterolemia, atherosclerosis, and fatty liver. J Am Heart Assoc 2013 0.81
14 Lethality in a murine model of pulmonary anthrax is reduced by combining nuclear transport modifier with antimicrobial therapy. PLoS One 2012 0.81
15 The innate immunity adaptor SARM translocates to the nucleus to stabilize lamins and prevent DNA fragmentation in response to pro-apoptotic signaling. PLoS One 2013 0.81
16 Cutting edge: the "death" adaptor CRADD/RAIDD targets BCL10 and suppresses agonist-induced cytokine expression in T lymphocytes. J Immunol 2012 0.80